AbbVie Inc. is 114.0x more valuable than Organon & Co. by market capitalization ($402.35 B vs $3.53 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | OGN | ABBV |
|---|---|---|
| Market cap | $3.53 B | $402.35 B |
| US-listed rank | #1699 | #31 |
| Revenue (latest FY) | $6.22B | $61.16B |
| Net income (latest FY) | $187.00M | $4.23B |
| Net margin | 3.0% | 6.9% |
| P/E (trailing FY) | 18.9 | 95.2 |
| SEC filings | 433 | 1,008 |
AbbVie Inc. is 114.0x more valuable than Organon & Co. by market capitalization ($402.35 B vs $3.53 B).
In their latest fiscal years, Organon & Co. reported $6.22B in revenue while AbbVie Inc. reported $61.16B.
Full pages: Organon & Co. and AbbVie Inc., or browse the full rankings.